This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Ali Amjad: Innovator in Neurological Treatments
Introduction
Ali Amjad is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurological disorders.
Latest Patents
Ali Amjad holds a patent for his invention titled "2,2-difluorodioxolo Areceptor antagonists." This invention focuses on 2,2-difluorodioxolo compounds that act as antagonists of Areceptors. The patent outlines the potential uses of these compounds in the treatment or prevention of neurological disorders and diseases associated with Areceptors. Additionally, it includes pharmaceutical compositions that incorporate these compounds for therapeutic applications.
Career Highlights
Ali Amjad is affiliated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His work at Merck has allowed him to contribute to innovative solutions in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Gioconda V Gallo and Timothy J Henderson, who have collaborated with him on various projects within the company.
Conclusion
Ali Amjad's work in developing Areceptor antagonists represents a significant advancement in the treatment of neurological disorders. His contributions continue to impact the pharmaceutical landscape positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile